GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing SL Pharmaceutical Co Ltd (SZSE:002038) » Definitions » Cyclically Adjusted FCF per Share

Beijing SL Pharmaceutical Co (SZSE:002038) Cyclically Adjusted FCF per Share : ¥0.26 (As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Beijing SL Pharmaceutical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Beijing SL Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Sep. 2024 was ¥-0.047. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.26 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Beijing SL Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was -10.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 1.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 3.30% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Beijing SL Pharmaceutical Co was 20.00% per year. The lowest was 1.20% per year. And the median was 6.80% per year.

As of today (2024-12-15), Beijing SL Pharmaceutical Co's current stock price is ¥7.50. Beijing SL Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2024 was ¥0.26. Beijing SL Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 28.85.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Beijing SL Pharmaceutical Co was 198.03. The lowest was 22.57. And the median was 47.60.


Beijing SL Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Beijing SL Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing SL Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Beijing SL Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.27 0.28 0.29 0.28

Beijing SL Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.28 0.29 0.28 0.26

Competitive Comparison of Beijing SL Pharmaceutical Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing SL Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing SL Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing SL Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Beijing SL Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Beijing SL Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Beijing SL Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.047/115.7848*115.7848
=-0.047

Current CPI (Sep. 2024) = 115.7848.

Beijing SL Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.062 99.000 0.073
201503 0.125 99.900 0.145
201506 0.061 99.500 0.071
201509 0.084 100.500 0.097
201512 0.095 100.600 0.109
201603 0.033 102.200 0.037
201606 0.052 101.400 0.059
201609 0.035 102.400 0.040
201612 0.106 102.600 0.120
201703 0.053 103.200 0.059
201706 0.084 103.100 0.094
201709 -0.027 104.100 -0.030
201712 0.040 104.500 0.044
201803 0.095 105.300 0.104
201806 0.048 104.900 0.053
201809 0.095 106.600 0.103
201812 0.020 106.500 0.022
201903 0.276 107.700 0.297
201906 0.178 107.700 0.191
201909 0.085 109.800 0.090
201912 -0.005 111.200 -0.005
202003 0.027 112.300 0.028
202006 -0.001 110.400 -0.001
202009 0.041 111.700 0.042
202012 0.094 111.500 0.098
202103 0.051 112.662 0.052
202106 0.081 111.769 0.084
202109 0.030 112.215 0.031
202112 0.057 113.108 0.058
202203 0.053 114.335 0.054
202206 0.066 114.558 0.067
202209 0.067 115.339 0.067
202212 0.036 115.116 0.036
202303 0.080 115.116 0.080
202306 0.028 114.558 0.028
202309 -0.007 115.339 -0.007
202312 0.141 114.781 0.142
202403 0.080 115.227 0.080
202406 -0.026 114.781 -0.026
202409 -0.047 115.785 -0.047

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Beijing SL Pharmaceutical Co  (SZSE:002038) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Beijing SL Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=7.50/0.26
=28.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Beijing SL Pharmaceutical Co was 198.03. The lowest was 22.57. And the median was 47.60.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Beijing SL Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Beijing SL Pharmaceutical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing SL Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.69 Fu shi Road, No.1 Building, Bitongyuan, Haidian district, Beijing, CHN, 100049
Beijing SL Pharmaceutical Co Ltd is a Chinese biotechnology-pharmaceutical company. It is principally focused on developing and marketing gene engineering drugs. The product portfolio of the company includes drugs for Oncology, Hepatopathy and Senile disease. Its products include Filgrastim, Asparaginase, Dasartinib, Enoxaparin, Naftopidil, Ademetionine, Lenalidomide, and others.
Executives
Liang Shu Jie Secretary, Director
Xu Ming Bo Directors, executives
Yang Zhong Fan Supervisors
Chen Yu Lin Director
Qi Yan Ming Supervisors
Xi Wen Ying Executives
Wu Yan Zhuo Executives
Wang Wen Xin Director
Li Ya Jun Executives
Zhao Xia Securities Affairs Representative
Zhang Chun Lei Supervisors
Wang Yong Bo Directors, executives
Lu An Jing Supervisors
Wei Su Yan Director

Beijing SL Pharmaceutical Co Headlines

No Headlines